MOODY ALDRICH PARTNERS LLC - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 278 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.

Quarter-by-quarter ownership
MOODY ALDRICH PARTNERS LLC ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q4 2020$4,694,000
+117.0%
101,161
+54.0%
0.76%
+67.7%
Q3 2020$2,163,000
+21.7%
65,707
+1.5%
0.45%
+19.6%
Q2 2020$1,778,000
-29.9%
64,755
-23.6%
0.38%
-50.7%
Q1 2020$2,538,000
+8.0%
84,785
-0.1%
0.77%
+58.6%
Q4 2019$2,349,000
+54.4%
84,874
+1.6%
0.48%
+19.6%
Q3 2019$1,521,000
-26.5%
83,563
-1.0%
0.40%
-23.6%
Q2 2019$2,070,00084,4050.53%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 565,890$26,257,0009.39%
Consonance Capital Management LP 1,710,803$79,381,0007.41%
GREAT POINT PARTNERS LLC 917,427$42,569,0006.91%
Avoro Capital Advisors LLC 7,500,000$348,000,0005.99%
Ghost Tree Capital, LLC 500,000$23,200,0005.17%
FRAZIER MANAGEMENT LLC 1,312,999$60,923,0004.69%
Perceptive Advisors 9,166,304$425,316,0004.56%
Ally Bridge Group (NY) LLC 360,000$16,704,0002.86%
Orbimed Advisors 6,645,100$308,333,0002.70%
ACUTA CAPITAL PARTNERS, LLC 164,800$7,647,0002.08%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders